Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
 | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
 |  |  |  | ||||||
| MAP2K2 | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 1.14E5 | Evidence |
O
|
||||
| MAP2K2 | BRAF | BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase | 8.47E4 | Evidence |
O
|
||||
| MAP2K2 | NRAS | NRAS, HRAS1: GTPase NRas precursor | 9.58E3 | Evidence | |||||
| MAP2K2 | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 9.49E3 | Evidence |
O
|
||||
| MAP2K2 | RPS6KA5 | RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 | 3.18E3 | Evidence | |||||
| MAP2K2 | RPS6KA3 | RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 | 850.0 | Evidence | |||||
| MAP2K2 | GAPD | GAPDH, GAPD, CDABP0047, OK/SW-cl.12: Glyceraldehyde-3-phosphate dehydrogenase | 343.0 | Evidence | |||||
| MAP2K2 | AKT1 | AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase | 105.0 | Evidence | |||||
| MAP2K2 | PRKCI | PRKCI, DXS1179E: Protein kinase C iota type | 71.10 | Evidence | |||||
| MAP2K2 | VAV1 | VAV1, VAV: Proto-oncogene vav | 62.90 | Evidence | |||||
| MAP2K2 | IRAK1 | IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 | 53.3 | Evidence | |||||
| MAP2K2 | PSMA3 | PSMA3, PSC8: Proteasome subunit alpha type-3 | 51.60 | Evidence | |||||
| MAP2K2 | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 51.50 | Evidence | |||||
| MAP2K2 | JAK1 | 51.50 | Evidence | ||||||
| MAP2K2 | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 43.60 | Evidence | O | ||||
| MAP2K2 | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 43.60 | Evidence | |||||
| MAP2K2 | HSP90AA1 | Hsp89-alpha-delta-N | 43.00 | Evidence | |||||
| MAP2K2 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 38.10 | Evidence | |||||
| MAP2K2 | SQSTM1 | SQSTM1: Uncharacterized protein SQSTM1 | 34.80 | Evidence | |||||
| MAP2K2 | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 33.90 | Evidence | |||||
| MAP2K2 | SPTBN1 | SPTBN1, SPTB2: Spectrin beta chain, brain 1 | 33.90 | Evidence | |||||
| MAP2K2 | CDC25A | CDC25A: M-phase inducer phosphatase 1 | 33.90 | Evidence | |||||
| MAP2K2 | LYN | LYN: Tyrosine-protein kinase Lyn | 32.80 | Evidence | |||||
| MAP2K2 | DOCK2 | DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 | 31.70 | Evidence | |||||
| MAP2K2 | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 31.70 | Evidence |
O
|
||||
| MAP2K2 | NAP1L1 | NAP1L1, NRP: Nucleosome assembly protein 1-like 1 | 31.40 | Evidence | |||||
| MAP2K2 | CFLAR | CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec | 29.00 | Evidence | |||||
| MAP2K2 | RB1 | RB1: Retinoblastoma-associated protein | 28.30 | Evidence | |||||
| MAP2K2 | RAP1A | RAP1A, KREV1: Ras-related protein Rap-1A precursor | 26.90 | Evidence | |||||
| MAP2K2 | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 26.80 | Evidence | |||||
| MAP2K2 | SYK | SYK: Tyrosine-protein kinase SYK | 26.80 | Evidence | |||||
| MAP2K2 | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 26.40 | Evidence | |||||
-